Neonc Technologies (NASDAQ:NTHI) President Acquires $41,600.00 in Stock

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) President Amir Heshmatpour bought 10,000 shares of the business’s stock in a transaction dated Friday, May 1st. The stock was acquired at an average price of $4.16 per share, for a total transaction of $41,600.00. Following the purchase, the president directly owned 3,072,000 shares in the company, valued at approximately $12,779,520. The trade was a 0.33% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this link.

Neonc Technologies Trading Up 1.4%

Shares of NASDAQ:NTHI traded up $0.06 during mid-day trading on Monday, reaching $4.12. The company had a trading volume of 27,958 shares, compared to its average volume of 55,675. The company’s 50-day moving average price is $7.20 and its 200-day moving average price is $8.44. Neonc Technologies Holdings, Inc. has a one year low of $3.20 and a one year high of $12.99.

Institutional Investors Weigh In On Neonc Technologies

Hedge funds and other institutional investors have recently bought and sold shares of the business. Barclays PLC raised its holdings in Neonc Technologies by 5,314.8% during the 4th quarter. Barclays PLC now owns 9,151 shares of the company’s stock valued at $76,000 after acquiring an additional 8,982 shares during the period. Foundations Investment Advisors LLC bought a new stake in Neonc Technologies during the 3rd quarter valued at $100,000. SLT Holdings LLC bought a new stake in Neonc Technologies during the 3rd quarter valued at $100,000. Goldman Sachs Group Inc. bought a new stake in Neonc Technologies during the 4th quarter valued at $124,000. Finally, OMERS ADMINISTRATION Corp bought a new stake in Neonc Technologies during the 4th quarter valued at $126,000.

Analyst Ratings Changes

A number of equities research analysts recently commented on the stock. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Neonc Technologies in a report on Friday, March 27th. Zacks Research raised shares of Neonc Technologies to a “hold” rating in a report on Wednesday, January 14th. Finally, BTIG Research assumed coverage on shares of Neonc Technologies in a report on Friday, April 24th. They issued a “buy” rating and a $15.00 price target on the stock. One research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $15.00.

About Neonc Technologies

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.